273 related articles for article (PubMed ID: 21235822)
1. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol.
Askie LM; Brocklehurst P; Darlow BA; Finer N; Schmidt B; Tarnow-Mordi W;
BMC Pediatr; 2011 Jan; 11():6. PubMed ID: 21235822
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2009 Jan; (1):CD001146. PubMed ID: 19160190
[TBL] [Abstract][Full Text] [Related]
4. Oxygen Saturation Targets for Extremely Preterm Infants after the NeOProM Trials.
Stenson BJ
Neonatology; 2016; 109(4):352-8. PubMed ID: 27250557
[TBL] [Abstract][Full Text] [Related]
5. Effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO
Maiwald CA; Niemarkt HJ; Poets CF; Urschitz MS; König J; Hummler H; Bassler D; Engel C; Franz AR;
BMC Pediatr; 2019 Oct; 19(1):363. PubMed ID: 31630690
[TBL] [Abstract][Full Text] [Related]
6. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
[TBL] [Abstract][Full Text] [Related]
7. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial.
Schmidt B; Whyte RK; Asztalos EV; Moddemann D; Poets C; Rabi Y; Solimano A; Roberts RS;
JAMA; 2013 May; 309(20):2111-20. PubMed ID: 23644995
[TBL] [Abstract][Full Text] [Related]
8. Oxygenation of the Immature Infant: A Commentary and Recommendations for Oxygen Saturation Targets and Alarm Limits.
Saugstad OD
Neonatology; 2018; 114(1):69-75. PubMed ID: 29669357
[TBL] [Abstract][Full Text] [Related]
9. Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis.
Manja V; Lakshminrusimha S; Cook DJ
JAMA Pediatr; 2015 Apr; 169(4):332-40. PubMed ID: 25664703
[TBL] [Abstract][Full Text] [Related]
10. A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.
Hyttel-Sorensen S; Austin T; van Bel F; Benders M; Claris O; Dempsey E; Fumagalli M; Greisen G; Grevstad B; Hagmann C; Hellström-Westas L; Lemmers P; Lindschou J; Naulaers G; van Oeveren W; Pellicer A; Pichler G; Roll C; Skoog M; Winkel P; Wolf M; Gluud C
Trials; 2013 May; 14():120. PubMed ID: 23782447
[TBL] [Abstract][Full Text] [Related]
11. Primary prevention of ROP and the oxygen saturation targeting trials.
Darlow BA; Husain S
Semin Perinatol; 2019 Oct; 43(6):333-340. PubMed ID: 31151776
[TBL] [Abstract][Full Text] [Related]
12. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants.
Askie LM; Henderson-Smart DJ
Cochrane Database Syst Rev; 2001; (4):CD001077. PubMed ID: 11687096
[TBL] [Abstract][Full Text] [Related]
13. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants.
Askie LM; Henderson-Smart DJ; Ko H
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD001077. PubMed ID: 19160188
[TBL] [Abstract][Full Text] [Related]
14. Target ranges of oxygen saturation in extremely preterm infants.
; Carlo WA; Finer NN; Walsh MC; Rich W; Gantz MG; Laptook AR; Yoder BA; Faix RG; Das A; Poole WK; Schibler K; Newman NS; Ambalavanan N; Frantz ID; Piazza AJ; Sánchez PJ; Morris BH; Laroia N; Phelps DL; Poindexter BB; Cotten CM; Van Meurs KP; Duara S; Narendran V; Sood BG; O'Shea TM; Bell EF; Ehrenkranz RA; Watterberg KL; Higgins RD
N Engl J Med; 2010 May; 362(21):1959-69. PubMed ID: 20472937
[TBL] [Abstract][Full Text] [Related]
15. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Doyle LW; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
[TBL] [Abstract][Full Text] [Related]
16. Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies.
Saugstad OD; Aune D
Neonatology; 2014; 105(1):55-63. PubMed ID: 24247112
[TBL] [Abstract][Full Text] [Related]
17. Oxygen and retinopathy of prematurity.
Saugstad OD
J Perinatol; 2006 May; 26 Suppl 1():S46-50; discussion S63-4. PubMed ID: 16482198
[TBL] [Abstract][Full Text] [Related]
18. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
[TBL] [Abstract][Full Text] [Related]
19. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
20. Cromolyn sodium for the prevention of chronic lung disease in preterm infants.
Ng GY; Ohlsson A
Cochrane Database Syst Rev; 2001; (2):CD003059. PubMed ID: 11406065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
